Astrana Health, Inc.
ASTHNasdaqCIK 1083446IndustrialsFiscal year ends Dec 31
Reports and events: 372 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-09-0418:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-096952 |
| 2024-08-0918:55 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094262 |
| 2024-08-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086761 |
| 2024-07-2508:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-082519 |
| 2024-07-1516:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-079867 |
| 2024-06-1316:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-071275 |
| 2024-06-1216:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-070847 |
| 2024-05-2106:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-063598 |
| 2024-05-1506:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-061405 |
| 2024-05-0916:29 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-022272 |
| 2024-05-0716:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-058018 |
| 2024-04-2409:22 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001104659-24-050983 |
| 2024-04-2409:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-050973 |
| 2024-04-2406:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-050759 |
| 2024-04-0520:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-043762 |
| 2024-04-0216:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-042549 |
| 2024-03-1106:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-032624 |
| 2024-02-2916:50 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-008024 |
| 2024-02-2906:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-028972 |
| 2024-02-2716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-028213 |
| 2024-02-2606:04 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-027198 |
| 2024-02-0207:30 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-009754 |
| 2024-01-2607:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-006988 |
| 2024-01-2408:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001104659-24-006114 |
| 2024-01-1008:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-002804 |
| 2024-01-0216:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-000337 |
| 2023-11-3007:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-122223 |
| 2023-11-1716:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-119527 |
| 2023-11-1716:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-119518 |
| 2023-11-0915:19 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-038192 |
| 2023-11-0716:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115263 |
| 2023-11-0716:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-115255 |
| 2023-11-0716:20 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-115249 |
| 2023-11-0716:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-115243 |
| 2023-09-1309:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-100258 |
| 2023-09-0817:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-099360 |
| 2023-08-0917:26 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-03-31 | 0001628280-23-028677 |
| 2023-08-0917:24 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001628280-23-028675 |
| 2023-08-0917:20 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-028672 |
| 2023-08-0917:14 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-089366 |
| 2023-08-0717:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-088428 |
| 2023-08-0716:50 ET | 8-K | 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure | 0001104659-23-088394 |
| 2023-07-3108:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-085610 |
| 2023-07-1216:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-080323 |
| 2023-06-1616:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-072288 |
| 2023-06-0710:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-068765 |
| 2023-05-1013:49 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001628280-23-017118 |
| 2023-05-0816:43 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-016464 |
| 2023-04-2816:18 ET | DEF 14A | Proxy statement | 0001628280-23-014191 |
| 2023-03-1311:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-007660 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:58 ET. Listed shows no prices and gives no investment advice.